These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 17605216)

  • 21. Trypanocidal drugs: mechanisms, resistance and new targets.
    Wilkinson SR; Kelly JM
    Expert Rev Mol Med; 2009 Oct; 11():e31. PubMed ID: 19863838
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Congenital Chagas' disease: diagnostic and clinical aspects.
    Freilij H; Altcheh J
    Clin Infect Dis; 1995 Sep; 21(3):551-5. PubMed ID: 8527542
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Trypanosoma cruzi parasitemia in US blood donors with serologic evidence of infection.
    Leiby DA; Herron RM; Garratty G; Herwaldt BL
    J Infect Dis; 2008 Aug; 198(4):609-13. PubMed ID: 18588482
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Congenital Chagas disease: experience in the Hospital de Niños, Ricardo Gutiérrez, Buenos Aires, Argentina].
    Altcheh J; Biancardi M; Lapeña A; Ballering G; Freilij H
    Rev Soc Bras Med Trop; 2005; 38 Suppl 2():41-5. PubMed ID: 16482812
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aetiological treatment of congenital Chagas' disease diagnosed and monitored by the polymerase chain reaction.
    Schijman AG; Altcheh J; Burgos JM; Biancardi M; Bisio M; Levin MJ; Freilij H
    J Antimicrob Chemother; 2003 Sep; 52(3):441-9. PubMed ID: 12917253
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Recommendations for diagnosis, treatment and follow-up of the Trypanosoma cruzi: human immunodeficiency virus co-infection].
    Rev Soc Bras Med Trop; 2006; 39(4):392-415. PubMed ID: 17119760
    [No Abstract]   [Full Text] [Related]  

  • 27. Usefulness of PCR-based assays to assess drug efficacy in Chagas disease chemotherapy: value and limitations.
    Britto CC
    Mem Inst Oswaldo Cruz; 2009 Jul; 104 Suppl 1():122-35. PubMed ID: 19753467
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The chemotherapy of infections produced by Trypanosoma cruzi].
    López-Antuñano FJ
    Salud Publica Mex; 1997; 39(5):463-71. PubMed ID: 9424728
    [No Abstract]   [Full Text] [Related]  

  • 29. Trypanosoma cruzi: acute and long-term infection in the vertebrate host can modify the response to benznidazole.
    Caldas S; Santos FM; de Lana M; Diniz LF; Machado-Coelho GL; Veloso VM; Bahia MT
    Exp Parasitol; 2008 Mar; 118(3):315-23. PubMed ID: 17945216
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The value of molecular studies for the diagnosis of congenital Chagas disease in northeastern Argentina.
    Diez CN; Manattini S; Zanuttini JC; Bottasso O; Marcipar I
    Am J Trop Med Hyg; 2008 Apr; 78(4):624-7. PubMed ID: 18385359
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Part VI. Antiparasitic treatment for Chagas disease].
    B WA; G IH; L MI; M LJ; V PM; H IN; V AM; P JS; H MT; A IZ
    Rev Chilena Infectol; 2008 Oct; 25(5):384-9, discussion 387. PubMed ID: 18949153
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Trypanosoma cruzi: Induction of benznidazole resistance in vivo and its modulation by in vitro culturing and mice infection.
    Dos Santos FM; Caldas S; de Assis Cáu SB; Crepalde GP; de Lana M; Machado-Coelho GL; Veloso VM; Bahia MT
    Exp Parasitol; 2008 Dec; 120(4):385-90. PubMed ID: 18823980
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antichagasic activity of komaroviquinone is due to generation of reactive oxygen species catalyzed by Trypanosoma cruzi old yellow enzyme.
    Uchiyama N; Kabututu Z; Kubata BK; Kiuchi F; Ito M; Nakajima-Shimada J; Aoki T; Ohkubo K; Fukuzumi S; Martin SK; Honda G; Urade Y
    Antimicrob Agents Chemother; 2005 Dec; 49(12):5123-6. PubMed ID: 16304182
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chagas disease diagnosis using polymerase chain reaction, hemoculture and serologic methods.
    Chiari E
    Mem Inst Oswaldo Cruz; 1999; 94 Suppl 1():299-300. PubMed ID: 10677740
    [No Abstract]   [Full Text] [Related]  

  • 35. [Parasitological and epidemiological aspects of Trypanosoma cruzi seropositive blood donors].
    Galaz P; García S; Mercado R; Orrego E; Pagliero B; Contreras Mdel C; Salinas P; Arancibia C
    Rev Med Chil; 2007 Oct; 135(10):1291-5. PubMed ID: 18180836
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PCR and sero-diagnosis of chronic Chagas' disease. Biotechnological advances.
    Gomes YM
    Appl Biochem Biotechnol; 1997 May; 66(2):107-19. PubMed ID: 9248034
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Etiological treatment in patients infected by Trypanosoma cruzi: experiences in Argentina.
    Sosa-Estani S; Segura EL
    Curr Opin Infect Dis; 2006 Dec; 19(6):583-7. PubMed ID: 17075335
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Hemoculture in the LIT medium for Trypanosoma cruzi according to the Mourão-Mello method (1975)].
    Rassi A; Amato Neto V; de Oliveira RL
    Rev Inst Med Trop Sao Paulo; 1981; 23(2):57-60. PubMed ID: 6792687
    [No Abstract]   [Full Text] [Related]  

  • 39. Polymerase chain reaction detection and serologic follow-up after treatment with benznidazole in Bolivian children infected with a natural mixture of Trypanosoma cruzi I and II.
    Flores-Chavez M; Bosseno MF; Bastrenta B; Dalenz JL; Hontebeyrie M; Revollo S; Brenière SF
    Am J Trop Med Hyg; 2006 Sep; 75(3):497-501. PubMed ID: 16968928
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transmission of Trypanosoma cruzi by heart transplantation.
    Kun H; Moore A; Mascola L; Steurer F; Lawrence G; Kubak B; Radhakrishna S; Leiby D; Herron R; Mone T; Hunter R; Kuehnert M;
    Clin Infect Dis; 2009 Jun; 48(11):1534-40. PubMed ID: 19400748
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.